NCT00193037View on ClinicalTrials.gov

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 31, 2008

Study Completion Date

November 30, 2009

Conditions
Breast Cancer
Interventions
DRUG

Liposomal Doxorubicin

Liposomal Doxorubicin

DRUG

Docetaxel

Docetaxel

Trial Locations (1)

37203

Tennessee Oncology, Nashville

Sponsors
All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER